Macrophage p38 mitogen-activated protein kinase activity regulates invariant natural killer T-cell responses during borrelia burgdorferi infection

Journal of Infectious Diseases

Volumn 206, Issue 2, 2012, Pages 283-291

  Hawley, Kelly ^a   Navasa, Nicolás ^a   Olson, Chris M ^a,b,d   Bates, Tonya C ^a,b   Garg, Renu ^b,g   Hedrick, Michael N ^b,f   Conze, Dietrich ^c,e   Rincón, Mercedes ^c   Anguita, Juan ^a,b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e Spherix   (United States)

^f BRISTOL MYERS SQUIBB   (United States)

^g INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; CHEMOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANTIGEN PRESENTING CELL; ARTICLE; BORRELIA BURGDORFERI; CARDITIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNE RESPONSE; INTERFERON PRODUCTION; LYME DISEASE; MACROPHAGE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD1D; BORRELIA BURGDORFERI; GENE EXPRESSION REGULATION; HEART DISEASES; HOMEOSTASIS; IMIDAZOLES; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYME DISEASE; MACROPHAGES; MICE; MICE, TRANSGENIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES;

EID: 84862894256     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis332     Document Type: Article

References (48)

1. Wooten RM, Ma Y, Yoder RA, et al. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J Immunol 2002; 168:348-55
2. Behera AK, Hildebrand E, Uematsu S, Akira S, Coburn J, Hu LT. Identification of a TLR-independent pathway for Borrelia burgdorferiinduced expression of matrix metalloproteinases and inflammatory mediators through binding to integrin α3β1. J Immunol 2006; 177:657-64
3. Hirschfeld M, Kirschning CJ, Schwandner R, et al. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol 1999; 163:2382-6
4. Ebnet K, Brown KD, Siebenlist UK, Simon MM, Shaw S. Borrelia burgdorferi activates nuclear factor-kappa B and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts. J Immunol 1997; 158:3285-92
5. Anguita J, Barthold SW, Persinski R, et al. Murine Lyme arthritis development mediated by p38 mitogen-activated protein kinase activity. J Immunol 2002; 168:6352-7
6. Defosse DL, Johnson RC. In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi. Infect Immun 1992; 60:1109-13
7. Ma Y, Weis JJ. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun 1993; 61:3843-53
8. Olson CM Jr, Bates TC, Izadi H, et al. Local production of IFN-γ by invariant NKT cells modulates acute Lyme carditis. J Immunol 2009; 182:3728-34
9. Ip YT, Davis RJ. Signal transduction by the c-Jun N-terminal kinase ( JNK)-from inflammation to development. Curr Opin Cell Biol 1998; 10:205-19
10. Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 1996; 74:589-607
11. Raingeaud J, Gupta S, Rogers JS, et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995; 270:7420-6
12. Derijard B, Raingeaud J, Barrett T, et al. Independent human MAPkinase signal transduction pathways defined by MEK and MKK isoforms. Science 1995; 267:682-5
13. Han J, Lee JD, Jiang Y, Li Z, Feng L, Ulevitch RJ. Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J Biol Chem 1996; 271:2886-91
14. Moriguchi T, Kuroyanagi N, Yamaguchi K, et al. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J Biol Chem 1996; 271:13675-9
15. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Davis RJ. MKK3-and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 1996; 16:1247-55
16. Freshney NW, Rawlinson L, Guesdon F, et al. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 1994; 78:1039-49
17. Olson CM, Hedrick MN, Izadi H, Bates TC, Olivera ER, Anguita J. p38 mitogen-activated protein kinase controls NF-κB transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogen-and stress-activated protein kinase 1 in response to Borrelia burgdorferi antigens. Infect Immun 2007; 75:270-7
18. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994; 265:808-11
19. Lee JC, Laydon JT, McDonnell PC, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994; 372:739-46
20. Mavunkel BJ, Chakravarty S, Perumattam JJ, et al. Indole-based heterocyclic inhibitors of p38α MAP kinase: designing a conformationally restricted analogue. Bioorg Med Chem Lett 2003; 13:3087-90
21. Anand P, Shenoy R, Palmer JE, et al. Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury. Eur J Pain 2011; 15:1040-8
22. Genovese MC, Cohen SB, Wofsy D, et al. A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritis. J Rheumatol 2011; 38: 846-54
23. Yasuda S, Sugiura H, Tanaka H, Takigami S, Yamagata K. p38 MAP kinase inhibitors as potential therapeutic drugs for neural diseases. Cent Nerv Syst Agents Med Chem 2011; 11:45-59
24. Rincon M, Davis RJ. Regulation of the immune response by stressactivated protein kinases. Immunol Rev 2009; 228:212-24
25. Armstrong AL, Barthold SW, Persing DH, Beck DS. Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. Am J Trop Med Hyg 1992; 47:249-58
26. Barthold SW, Beck DS, Hansen GM, Terwilliger GA, Moody KD. Lyme borreliosis in selected strains and ages of laboratory mice. J Infect Dis 1990; 162:133-8
27. Ruderman EM, Kerr JS, Telford SR, Spielman A, Glimcher LH, Gravallese EM. Early murine Lyme carditis has a macrophage predominance and is independent of major histocompatibility complex class II-CD4+ T cell interactions. J Infect Dis 1995; 171:362-70
28. Zimmer G, Schaible UE, Kramer MD, Mall G, Museteanu C, Simon MM. Lyme carditis in immunodeficient mice during experimental infection of Borrelia burgdorferi. Virchows Arch A Pathol Anat Histopathol 1990; 417:129-35
29. Hedrick MN, Olson CM Jr, Conze DB, Bates TC, Rincon M, Anguita J. Control of Borrelia burgdorferi-specific CD4+ T-cell effector function by interleukin-12-and T-cell receptor-induced p38 mitogen-activated protein kinase activity. Infect Immun 2006; 74:5713-7
30. Dziennis S, Van Etten RA, Pahl HL, et al. The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic mice. Blood 1995; 85:319-29
31. Rincón M, Enslen H, Raingeaud J, et al. Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J 1998; 17:2817-29
32. Pal U, Wang P, Bao F, et al. Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis. J Exp Med 2008; 205:133-41
33. Barthold SW, Hodzic E, Tunev S, Feng S. Antibody-mediated disease remission in the mouse model of lyme borreliosis. Infect Immun 2006; 74:4817-25
34. Bolz DD, Sundsbak RS, Ma Y, et al. MyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J Immunol 2004; 173:2003-10
35. Wang X, Ma Y, Weis JH, Zachary JF, Kirschning CJ, Weis JJ. Relative contributions of innate and acquired host responses to bacterial control and arthritis development in Lyme disease. Infect Immun 2005; 73:657-60
36. Bockenstedt LK, Kang I, Chang C, Persing D, Hayday A, Barthold SW. CD4+ T helper 1 cells facilitate regression of murine Lyme carditis. Infect Immun 2001; 69:5264-9
37. Morrison TB, Ma Y, Weis JH, Weis JJ. Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR. J Clin Microbiol 1999; 37:987-92
38. Motameni AR, Bates TC, Juncadella IJ, Petty C, Hedrick MN, Anguita J. Distinct bacterial dissemination and disease outcome in mice subcutaneously infected with Borrelia burgdorferi in the midline of the back and the footpad. FEMS Immunol Med Microbiol 2005; 45: 279-84
39. Dunham-Ems SM, Caimano MJ, Pal U, et al. Live imaging reveals a biphasic mode of dissemination of Borrelia burgdorferi within ticks. J Clin Invest 2009; 119:3652-65
40. Blander JM, Medzhitov R. Regulation of phagosome maturation by signals from toll-like receptors. Science 2004; 304:1014-8
41. Nowak M, Arredouani MS, Tun-Kyi A, et al. Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with alpha-galactosylceramide. PLoS One 2010; 5: e11311
42. Song L, Ara T, Wu HW, et al. Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma. J Clin Invest 2007; 117:2702-12
43. Kawakami K, Kinjo Y, Uezu K, et al. Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J Immunol 2001; 167:6525-32
44. Renukaradhya GJ, Webb TJ, Khan MA, et al. Virus-induced inhibition of CD1d1-mediated antigen presentation: reciprocal regulation by p38 and ERK. J Immunol 2005; 175:4301-8
45. Anguita J, Barthold SW, Samanta S, Ryan J, Fikrig E. Selective anti-inflammatory action of interleukin-11 in murine Lyme disease: arthritis decreases while carditis persists. J Infect Dis 1999; 179:734-7
46. Brown CR, Blaho VA, Fritsche KL, Loiacono CM. Stat1 deficiency exacerbates carditis but not arthritis during experimental lyme borreliosis. J Interferon Cytokine Res 2006; 26:390-9
47. Nagaleekar VK, Sabio G, Aktan I, et al. Translational control of NKT cell cytokine production by p38 MAPK. J Immunol 2011; 186:4140-6
48. Yadav A, Saini V, Arora S. MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta 2010; 411:1570-9